What is the translation of " SEROCONVERSION " in Danish?

• serokonvertering
• serokonversion
• konvertering
• sero- konvertering

Examples of using Seroconversion in English and their translations into Danish

Seroconversion/ Significant increase rate GMR.
Sero- konvertering/ signifikant stigning GMR.

YMDD variant HBV status HBeAg seroconversion.
(nr.) YMDD- variant HBV status HBeAg- serokonversion.

HBeAg Seroconversion*p value vs lamivudine< 0.05 a.
HBeAg- serokonvertering* p- værdi vs lamivudin< 0, 05 a.

However, relapse following seroconversion can occur.
Der kan dog forekomme tilbagefald efter serokonversion.

Seroconversion/ Significant increase rate GMTR.
Serokonvertering/ signifi- kant stigning Serokonverteringsfaktor GMTR.

Five patients achieved and maintained HBsAg seroconversion HBsAg negative/ HBsAb positive.
Fem af patienterne opnåede og opretholdt HBsAg- serokonversion HBsAg negativ/ HBsAb positiv.

HBs seroconversion or there is evidence of loss of efficacy.
HBs- serokonversion, eller indtil der er tegn på manglende virkning.

A trend towards higher rates of HBeAg loss(35% vs 29%) and seroconversion(30% vs 25%) was also observed for telbivudine.
Der var også en tendens mod højere hyppighed af HBeAg tab(35% vs 29%) og serokonvertering(30% vs 25%) for telbivudin.

Seroconversion. Usually presents two to six weeks after the exchange of fluids.
Kommer normalt to-seks uger efter udveksling af kropsvæsker. Serokonversion.

The net effect of these changes after seroconversion was an increase in exposure of 2- to 3-fold based on AUC and Cmax.
Nettoeffekten af disse ændringer efter serokonvertering var en 2- 3 gange eksponeringsforøgelse baseret på AUC og Cmax.

No unexpected safety issues were encountered in patients with an increase in exposure after seroconversion.
Ingen uventede problemer med sikkerhed blev der observeret hos patienter, som oplevede en eksponeringsforøgelse efter serokonvertering.

Thus seroconversion is expected to occur in most patients treated with Myozyme.
Serokonvertering forventes således at optræde hos de fleste patienter, der behandles med Myozyme.

In HBeAg negative patients, treatment should be administered at least until HBs seroconversion or there is evidence of loss of efficacy.
HBeAg- negative patienter skal behandles mindst indtil HBs- serokonvertering, eller indtil behandlingen ikke virker.

HBeAg seroconversion and loss assessed only in patients with detectable HBeAg at baseline.*p< 0.0001.
HBeAg- serokonvertering og- tab kun vurderet hos patienter med detekterbart HBeAg ved forsøgsstart.* p< 0, 0001.

Uniformly high(97.9% to 99.8% across all studies), seroconversion has not been shown to correlate well with protection.
Mens serokonverteringsraten for skoldkopper var lige høj i alle 22 forsøgene(97, 9% til 99, 8%), er det ikke vist at serokonvertering korrelerer godt til beskyttelse.

After IgG seroconversion, clearance decreased to 35 ml/ min, Vss increased to 5.4 l, and half-life increased to 240 min.
Efter IgG serokonvertering aftog clearance til 35 mL/ min, Vss steg til 5, 4 L og halveringstiden steg til 240 minutter.

However, in field studies 10% of seronegative dogs did not show seroconversion(> 0.1 IU/ml) 3-4 weeks after single primary vaccination against rabies.
Feltstudier viste 10% af seronegative hunde dog ikke serokonvertion(≥0,1 IE/ml) 3-4 uger efter en enkelt basisvaccination mod rabies.

HBeAg seroconversion was increased in patients with elevated ALT levels; 77%(20/ 26) of patients with pre-treatment ALT> 2 x ULN seroconverted.
HBeAg- serokonversion var øget hos patienter med forhøjede ALAT- niveauer; 77%(20/ 26) patienter, med præ- behandling ALAT> 2 x ULN, serokonverterede.

Baseline ALT levels> 2 x ULN and baseline HBV DNA< 9 log10 copies/ ml were associated with higher rates of eAg seroconversion in HBeAg-positive patients.
Udgangsniveauer for ALT 2 x ULN og udgangsværdier for HBV- DNA 9 log10 kopier/ ml var ledsaget af en større grad af eAg serokonvertering blandt HBeAg- positive- patienter.

Following HBeAg seroconversion, serologic response and clinical remission are generally durable after stopping lamivudine.
Efter HBeAg- serokonversion er serologisk respons og klinisk bedring generelt vedvarende når behandling med lamivudin stoppes.

Of those HBeAg positive subjects, 95% achieved non-detectable HBV DNA, 39% achieved HBeAg seroconversion, 90% achieved ALT normalisation at week 52 and 0.5% exhibited resistance at week 48.
Af disse HBeAg- positive personer havde 95% stadig ikke- detekterbart HBV- DNA, 39% havde opnået HBeAg- serokonvertering og 90% havde opnået ALT- normalisering i uge 52.

The seroprotection rate*, seroconversion rate* and the seroconversion factor** for anti-HA antibody in the adults measured by SRH were as follows.
Serumbeskyttelse*, konvertering* og konverteringsfaktor** for anti- HA antistof hos voksne målt med SRH var som følger.

Continued lamivudine treatment for an additional 2 years in patients who had failed to achieve HBeAg seroconversion in the initial 1 year controlled studies resulted in further improvement in bridging fibrosis.
Fortsat lamivudinbehandling i yderligere 2 år hos patienter, som ikke opnåede HBeAg- serokonversion i de initiale 1 års kontrollerede studier, resulterede i yderligere forbedring i brofibrose.

In these studies seroconversion in response to vaccination against measles, mumps, and rubella paralleled protection from these diseases.
I disse undersøgelser svarede serokonverteringen som reaktion på vaccination mod mæslinger, fåresyge og røde hunde til beskyttelse mod disse sygdomme.

In the HBeAg positive study, treatment beyond 48 weeks resulted in further reductions in serum HBV DNA levels and increases in the proportion of patients with ALT normalisation, HBeAg loss and seroconversion.
I undersøgelsen med HBeAg- positive patienter resulterede behandling i mere end 48 uger i yderligere reduktioner af serum- HBV- DNA- niveauerne samt i en øget andel af patienter med ALAT- normalisering, HBeAg- tab og serokonversion.

Therefore, following HBeAg seroconversion, patients should be periodically monitored to determine that serologic and clinical responses are being maintained.
Efter HBeAg- serokonversion bør patienterne derfor monitoreres periodisk for at afgøre om det serologiske og kliniske respons opretholdes.

Treatment with entecavir for up to 96 weeks(n 354) resulted in cumulative response rates of 80% for HBV DNA< 300 copies/ ml by PCR, 87% for ALT normalisation, 31% for HBeAg seroconversion and 2% for HBsAg seroconversion 5% for HBsAg loss.
Behandling med entecavir i op til 96 uger(n 354) gav kumulative responsrater på 80% for HBV DNA< 300 kopier/ ml ved PCR, 87% for ALAT- normalisering, 31% for HBeAg- serokonvertering og 2% for HBsAg- serokonvertering 5% for HBsAg- tab.

The seroprotection rate*, seroconversion rate* and the seroconversion factor** for anti-HA antibody in subjects aged over 60 measured by SRH were as follows.
Serumbeskyttelse*, konvertering* og konverteringsfaktor** for anti- HA antistof hos probander over 60 år målt med SRH- assay var som følger.

The Kaplan-Meier estimates of the proportion of patients who maintained HBeAg seroconversion for at least 52 weeks following treatment discontinuation were 86.2% for telbivudine and 92.8% for lamivudine.
Kaplan- Meier estimaterne for andelen af patienter, der opretholdt HBeAg serokonvertering i minimum 52 uger efter seponering af behandlingen, var 86, 2% for telbivudin og 92, 8% for lamivudin.

While the seroconversion rate for varicella was uniformly high(97.9% to 99.8% across all studies), seroconversion has not been shown to correlate well with protection.
Mens serokonverteringsraten for skoldkopper var lige høj i alle forsøgene(97, 9% til 99, 8%), er det ikke vist at serokonvertering korrelerer godt til beskyttelse.

How to use "seroconversion" in an English sentence

Seek specialist advice if no seroconversion after 2nd dose.

Seroconversion was assessed in the Per Protocol Analysis Set.

Prolonged seroconversion in an elite controller of HIV-1 infection.

Conclusion: HIV seroconversion was associated with complications during delivery.

Although the seroconversion might be false-positive, cases of S.

In lab diagnosis of Legionella, seroconversion must be seen.

The rate of seroconversion was independent of follow-up duration.

Infect. 13:100–108. (1988) Timing of seroconversion in Legionnaires' disease.

Group I developed higher seroconversion rates at month 3.

HBeAg seroconversion does not always indicate quiescent disease, however.

How to use "serokonvertering, serokonversion, konvertering" in a Danish sentence

Behandlingsvarigheden er mindst ½-1 år efter HBe-serokonvertering og optimalt til HBs-konvertering.

Indgivelse af hepatitis B-immunglobulin skal muligvis gentages, til der konstateres serokonvertering efter vaccination.

Bil lån dnb Symptomer kommer samtidig med såkaldt serokonversion.

Der var kun tale om en konvertering af data, dvs.

Der kan være behov for at give ekstra doser eller større antigendosis for at opnå serokonvertering.

Efter serokonversion, virus niveauer er lav og replikering fortsætter langsomt.

Hos HBeAg-negative pædiatriske patienter bør behandlingen administreres indtil HBs- serokonvertering, eller indtil behandlingen ikke virker.

Microsoft Excel omfatter ikke filformatkonverteringsprogrammer til direkte konvertering af projektmappefiler til Multiplan-formatet.

IgM antistoffer (fra 3 dage efter udslæt, persisterer i 2-4 mdr.), eller IgG serokonvertering i efterfølgende serumprøve taget efter 2 uger.

Der blev ikke observeret nogen uventede sikkerhedsproblemer hos patienter, som oplevede en eksponeringsforøgelse efter serokonvertering.